@therestoreclinic's testosterone advice needs context

What did @therestoreclinic actually say?

The creator reviewed a viewer's TRT protocol and raised three specific objections. First, that starting at 200mg of testosterone cypionate weekly is "rather aggressive." Second, that being on both HCG and clomiphene simultaneously is redundant, and possibly a way for the prescribing clinic to "charge you for two drugs when you probably only need one or the other." Third, that putting a TRT newcomer on three medications at once makes it impossible to identify the source of any adverse reaction. These are real clinical concerns worth examining, not just opinion.

The creator also noted some confusion around HCG dosing, pointing out that 0.13ml twice weekly produces different IU totals depending on whether the HCG is compounded at 1000 IU/ml or 2000 IU/ml. That is a fair observation about how concentration differences create dosing ambiguity in compounded preparations versus brand-name products.

Does the science back this up?

On the starting dose question, yes, largely. Most evidence-based TRT guidelines lean toward conservative initiation. The Endocrine Society's 2018 clinical practice guidelines recommend starting hypogonadal men at doses in the range that produce mid-normal physiological testosterone levels, not supraphysiologic ones. A 200mg weekly injection of testosterone cypionate typically pushes many men significantly above the normal reference range at peak.

Ramasamy et al. (2014, Journal of Urology) documented that aggressive testosterone dosing in younger men correlates with faster suppression of the hypothalamic-pituitary-gonadal axis, which is directly relevant when fertility preservation is a concern. On the HCG plus clomiphene combination, the pharmacological overlap is real. Both agents work upstream to stimulate luteinizing hormone (LH) activity, either directly (HCG) or indirectly via GnRH stimulation (clomiphene). Combining them is not standard practice in evidence-based TRT protocols. A 2019 review by Krzastek et al. in Translational Andrology and Urology found no clinical benefit data supporting dual use of these agents together in men already on exogenous testosterone.

What did they get right, and what needs a closer look?

The creator gets genuine credit for flagging the "too many variables" problem. This is not just opinion. It reflects a basic principle of clinical titration. When you start a patient on three interacting medications simultaneously, adverse events become difficult to attribute, and dose adjustments become guesswork. That critique is sound.

The claim that the clinic added both drugs primarily to generate revenue is harder to verify and is frankly speculative. It may be true in some cases. It may also reflect a prescriber who was trained in a particular protocol, or who was trying to aggressively protect fertility from day one. Attributing motive to a clinic you have no access to is editorializing, and listeners should recognize that distinction.

The HCG concentration point is worth flagging separately. The creator is right that compounded HCG and brand-name Pregnyl differ in concentration presentation, but compounded preparations are not equivalent to FDA-approved products in terms of regulatory oversight. That distinction matters when patients are making decisions about their care.

What should you actually know?

If you are starting TRT, the most defensible approach based on current evidence is to begin at a conservative dose, assess labs after 6 to 8 weeks, and add adjunct therapies only if there is a specific clinical reason, such as documented fertility concerns or testicular atrophy. The American Urological Association's 2018 guidelines on testosterone deficiency support this stepwise approach.

HCG and clomiphene are not interchangeable, and they are not the same drug. HCG directly mimics LH at the testicular level. Clomiphene works centrally by blocking estrogen receptors to increase endogenous LH and FSH. Some clinicians use clomiphene as a standalone alternative to testosterone. Using both alongside exogenous testosterone is an unusual combination and, as the creator suggests, one without strong evidence backing it. If your clinic has you on three medications on day one, asking why each one is necessary is a completely reasonable question.

• Starting testosterone doses above 100mg weekly may push many men into supraphysiologic peak levels depending on injection frequency and individual metabolism.
• Clomiphene and HCG have overlapping but mechanistically distinct actions. Dual use lacks strong clinical trial support.
• Compounded HCG preparations vary in concentration, which affects how patients interpret volume-based dosing instructions.
• A tiered approach to TRT initiation, one drug at a time, allows cleaner identification of side effects and easier dose adjustment.